Literature DB >> 19232760

The significance of patent foramen ovale: a current review of associated conditions and treatment.

Magnus C Johansson1, Peter Eriksson, Mikael Dellborg.   

Abstract

Patent foramen ovale (PFO) is a remnant of the foetal circulation, found in about a quarter of the population. PFO is an asymptomatic condition and the high prevalence infers that it is in most cases of no or only limited clinical significance. However, recent research has found an increased prevalence of PFO in cryptogenic stroke, decompression illness and migraine. The presence of a PFO has also been associated with oxygen desaturation in conditions such as obstructive pulmonary disease and obstructive sleep apnoea. The rapid evolution and widespread availability of catheter-based closing techniques have further stimulated interest. The seemingly growing significance of PFO will be discussed in this review.

Entities:  

Mesh:

Year:  2009        PMID: 19232760     DOI: 10.1016/j.ijcard.2009.01.049

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

1.  [Progressive dyspnoea in two patients with carcinoid syndrome].

Authors:  S Nölting; M Nicolaus; J Behr; R Baumgartner; H Mete; P Boekstegers; K Herrmann; D Theisen; M Lehrke; B Göke; J Schirra; C J Auernhammer
Journal:  Internist (Berl)       Date:  2010-11       Impact factor: 0.743

2.  Echocardiographic Follow-Up of Patent Foramen Ovale and the Factors Affecting Spontaneous Closure.

Authors:  Ali Yildirim; Alperen Aydin; Tevfik Demir; Fatma Aydin; Birsen Ucar; Zubeyir Kilic
Journal:  Acta Cardiol Sin       Date:  2016-11       Impact factor: 2.672

Review 3.  Point-of-care echocardiography for the evaluation of right-to-left cardiopulmonary shunts: a narrative review.

Authors:  Tim Montrief; Stephen Alerhand; André Denault; Jeffrey Scott
Journal:  Can J Anaesth       Date:  2020-09-17       Impact factor: 5.063

4.  Long-term follow-up after percutaneous closure of patent foramen ovale with Amplatzer PFO Occluder: a single center experience.

Authors:  Aleksander Araszkiewicz; Marek Grygier; Sylwia Iwańczyk; Olga Trojnarska; Maciej Lesiak; Stefan Grajek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-02-11       Impact factor: 1.426

5.  "Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism.

Authors:  Magdalena Kumor; Elżbieta K Biernacka; Marcin Demkow; Marek Konka; Anna E Płatek; Michalina Jagodzińska; Piotr Hoffman
Journal:  Postepy Kardiol Interwencyjnej       Date:  2014-09-11       Impact factor: 1.426

6.  Multidisciplinary assessment of PFO with substantial right-to-left shunting and medium-term follow-up after PFO device closure: A single-center experience.

Authors:  Lu He; Ge-Sheng Cheng; Ya-Juan Du; Yu-Shun Zhang
Journal:  J Interv Cardiol       Date:  2017-06-01       Impact factor: 2.279

7.  Absence of significant aortic regurgitation seven years after closure of patent foramen ovale.

Authors:  Naqibullah Mirzada; Per Ladenvall; Magnus C Johansson
Journal:  Int J Cardiol Heart Vessel       Date:  2014-07-27

8.  [Consensus on Perioperative Transesophageal Echocardiography of the Brazilian Society of Anesthesiology and the Department of Cardiovascular Image of the Brazilian Society of Cardiology].

Authors:  Marcello Fonseca Salgado-Filho; Samira Saady Morhy; Henrique Doria de Vasconcelos; Eric Benedet Lineburger; Fabio de Vasconcelos Papa; Eduardo Souza Leal Botelho; Marcelo Ramalho Fernandes; Maurício Daher; David Le Bihan; Chiara Scaglioni Tessmer Gatto; Cláudio Henrique Fischer; Alexander Alves da Silva; Carlos Galhardo Júnior; Carolina Baeta Neves; Alexandre Fernandes; Marcelo Luiz Campos Vieira
Journal:  Braz J Anesthesiol       Date:  2017-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.